Lipid-Lowering Drug Target Linked to Increased IBD Risk

A protein targeted by some marketed lipid-lowering agents may increase risk of developing irritable bowel disease.

Related Keywords

China ,Zhenyi ,Jiangsu ,Xuxu Liu ,Program In Complex Trait Genomics ,Unsplash National Cancer Institute ,First Affiliated Hospital Of Harbin Medical University ,National Cancer ,First Affiliated Hospital ,Harbin Medical University ,Complex Trait Genomics ,United Kingdom ,Lipid ,Lowering ,Drugs ,Ibd ,Risk ,Gastric ,Events ,Ulcerative Colitits ,Study ,Link ,Crohn X27s Disease ,